What Fueled The Previous Growth In The Buminate Market?
The buminate market has seen considerable growth due to a variety of factors.
• There has been a significant XX (HCAGR) growth in the Buminate market in the recent years. The market which was worth $XX million in 2024, is expected to surge to $XX million in 2025, progressing at a Compound Annual Growth Rate (CAGR) of XX%.
The noteworthy growth observed during the historic period is mainly due to regulatory policies, worldwide healthcare expenditure, increasing older population, growing instances of trauma and burns, and an enhanced awareness about liver diseases.
What Can Be Expected from the Buminate Market?
The buminate market is expected to maintain its strong growth trajectory in upcoming years.
• Predictions suggest significant growth in the Buminate market size in the coming years, with a FCAGR of XX%.
It is anticipated that by 2029, it will reach an impressive value of $XX million, with a compound annual growth rate (CAGR) of XX%.
Various factors contributing to this growth during the forecast period include the increasing instances of chronic diseases, wider acceptance of recombinant albumin, extension of plasma collection networks, along with its rising applications in surgical and trauma care, and finally, initiatives taken by the government. Additionally, future trends expected to influence this market during the forecast period are the implementation of cutting-edge technologies, the adoption of animal-free and recombinant technologies, advancements in plasma fractionation, along with strategic collaborations and mergers.
What Are The Core Factors Supporting Growth In The Buminate Market?
The buminate market is forecasted to grow due to the escalating rates of liver-related health issues. This encompasses a variety of conditions that disrupt the liver's proper function, including diseases such as cirrhosis, hepatitis, fatty liver disease, and liver cancer. These are often triggered by infections, toxins, genetics or prolonged alcohol consumption. Worldwide, liver disease rates are on the rise due to factors like increased obesity levels, metabolic disorders, alcohol intake, viral hepatitis, aging demographics, and environmental influences. Buminate, being a human albumin solution, assists in combating liver illnesses by enabling the restoration and sustenance of blood volume and osmotic pressure in patients suffering from diseases like cirrhosis or liver failure. This bolsters circulation, promotes appropriate fluid balance, and diminishes potential complications like edema and ascites. For instance, in April 2024, data from the Office for Health Improvement and Disparities, a UK-based governmental body, revealed that in 2022, premature morality due to liver disease in England increased to 21.4 per 100,000 population for those under 75 years of age. Male premature deaths were listed as 6,664 compared to 3,929 for females. As such, the rise in liver diseases is fuelling the growth of the buminate market.
How Is The Buminate Market segmented?
The buminate market covered in this report is segmented –
1) By Indication: Hypoproteinemia, Burn Treatment, Cardiopulmonary Bypass Surgery
2) By Distribution Channel: Hospital Pharmacies, Outpatient Clinics, Specialty Pharmacies
3) By End-Use: Hospitals, Clinics, Ambulatory Care, Home Care
Pre-Book The Buminate Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Who Are the Key Players In The Buminate Market?
Major companies operating in the buminate market include:
• Grifols S.A.
What Is The Most Dominant Region In The Buminate Market?
North America was the largest region in the buminate market in 2024. The regions covered in the buminate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
